Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 252

1.

A re-evaluation of the role of antidepressants in the treatment of bipolar depression: data from the Stanley Foundation Bipolar Network.

Post RM, Leverich GS, Nolen WA, Kupka RW, Altshuler LL, Frye MA, Suppes T, McElroy S, Keck P, Grunze H, Walden J; Stanley Foundation Bipolar Network.

Bipolar Disord. 2003 Dec;5(6):396-406. Review.

PMID:
14636363
2.

Rate of switch in bipolar patients prospectively treated with second-generation antidepressants as augmentation to mood stabilizers.

Post RM, Altshuler LL, Frye MA, Suppes T, Rush AJ, Keck PE Jr, McElroy SL, Denicoff KD, Leverich GS, Kupka R, Nolen WA.

Bipolar Disord. 2001 Oct;3(5):259-65.

PMID:
11912569
3.

Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers.

Leverich GS, Altshuler LL, Frye MA, Suppes T, McElroy SL, Keck PE Jr, Kupka RW, Denicoff KD, Nolen WA, Grunze H, Martinez MI, Post RM.

Am J Psychiatry. 2006 Feb;163(2):232-9.

PMID:
16449476
4.

Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up.

Altshuler L, Suppes T, Black D, Nolen WA, Keck PE Jr, Frye MA, McElroy S, Kupka R, Grunze H, Walden J, Leverich G, Denicoff K, Luckenbaugh D, Post R.

Am J Psychiatry. 2003 Jul;160(7):1252-62.

PMID:
12832239
5.

Bipolar depression and antidepressant-induced mania: a naturalistic study.

Boerlin HL, Gitlin MJ, Zoellner LA, Hammen CL.

J Clin Psychiatry. 1998 Jul;59(7):374-9.

PMID:
9714266
6.

The impact of antidepressant discontinuation versus antidepressant continuation on 1-year risk for relapse of bipolar depression: a retrospective chart review.

Altshuler L, Kiriakos L, Calcagno J, Goodman R, Gitlin M, Frye M, Mintz J.

J Clin Psychiatry. 2001 Aug;62(8):612-6.

PMID:
11561933
7.

Quetiapine for the continuation treatment of bipolar depression: naturalistic prospective case series from the Stanley Bipolar Treatment Network.

Suppes T, Kelly DI, Keck PE Jr, McElroy SL, Altshuler LL, Mintz J, Frye MA, Nolen WA, Luckenbaugh DA, Post RM, Leverich GS, Kupka RW, Grunze H.

Int Clin Psychopharmacol. 2007 Nov;22(6):376-81.

PMID:
17917557
9.

Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline.

Post RM, Altshuler LL, Leverich GS, Frye MA, Nolen WA, Kupka RW, Suppes T, McElroy S, Keck PE, Denicoff KD, Grunze H, Walden J, Kitchen CM, Mintz J.

Br J Psychiatry. 2006 Aug;189:124-31. Erratum in: Br J Psychiatry. 2006 Dec;189:569.

10.

Impact of antidepressant continuation after acute positive or partial treatment response for bipolar depression: a blinded, randomized study.

Altshuler LL, Post RM, Hellemann G, Leverich GS, Nolen WA, Frye MA, Keck PE Jr, Kupka RW, Grunze H, McElroy SL, Sugar CA, Suppes T.

J Clin Psychiatry. 2009 Apr;70(4):450-7. Epub 2009 Apr 7.

PMID:
19358785
11.

Safety and effectiveness of continuation antidepressant versus mood stabilizer monotherapy for relapse-prevention of bipolar II depression: A randomized, double-blind, parallel-group, prospective study.

Amsterdam JD, Lorenzo-Luaces L, Soeller I, Li SQ, Mao JJ, DeRubeis RJ.

J Affect Disord. 2015 Oct 1;185:31-7. doi: 10.1016/j.jad.2015.05.070. Epub 2015 Jun 26.

12.

Antidepressant-induced mania in bipolar patients: identification of risk factors.

Henry C, Sorbara F, Lacoste J, Gindre C, Leboyer M.

J Clin Psychiatry. 2001 Apr;62(4):249-55.

PMID:
11379838
13.

Antidepressant-associated switches from depression to mania in severe bipolar disorder.

Carlson GA, Finch SJ, Fochtmann LJ, Ye Q, Wang Q, Naz B, Bromet EJ.

Bipolar Disord. 2007 Dec;9(8):851-9.

PMID:
18076534
14.

An overview of recent findings of the Stanley Foundation Bipolar Network (Part I).

Post RM, Leverich GS, Altshuler LL, Frye MA, Suppes TM, Keck PE Jr, McElroy SL, Kupka R, Nolen WA, Grunze H, Walden J.

Bipolar Disord. 2003 Oct;5(5):310-9. Review.

PMID:
14525551
15.

A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder.

Bowden CL, Calabrese JR, Sachs G, Yatham LN, Asghar SA, Hompland M, Montgomery P, Earl N, Smoot TM, DeVeaugh-Geiss J; Lamictal 606 Study Group.

Arch Gen Psychiatry. 2003 Apr;60(4):392-400. Erratum in: Arch Gen Psychiatry. 2004 Jul;61(7):680.

PMID:
12695317
16.

The use of antidepressants in bipolar disorder.

Salvi V, Fagiolini A, Swartz HA, Maina G, Frank E.

J Clin Psychiatry. 2008 Aug;69(8):1307-18. Review.

PMID:
18681751
17.

Antidepressants in Type II Versus Type I Bipolar Depression: A Randomized Discontinuation Trial.

Vöhringer PA, Ostacher MJ, El-Mallakh RS, Holtzman NS, Thommi SB, Whitham EA, Sullivan MC, Baldassano CF, Goodwin FK, Baldessarini RJ, Ghaemi SN.

J Clin Psychopharmacol. 2015 Oct;35(5):605-8. doi: 10.1097/JCP.0000000000000384.

18.

Mood stabilizer augmentation in apparently "unipolar" MDD: predictors of response in the naturalistic French national EPIDEP study.

Hantouche EG, Akiskal HS, Lancrenon S, Chatenêt-Duchêne L.

J Affect Disord. 2005 Feb;84(2-3):243-9.

PMID:
15708422
19.

ECNP consensus meeting. Bipolar depression. Nice, March 2007.

Goodwin GM, Anderson I, Arango C, Bowden CL, Henry C, Mitchell PB, Nolen WA, Vieta E, Wittchen HU.

Eur Neuropsychopharmacol. 2008 Jul;18(7):535-49. doi: 10.1016/j.euroneuro.2008.03.003. Epub 2008 May 23. Review.

PMID:
18501566
20.

Treatment-emergent mania/hypomania during antidepressant monotherapy in patients with rapid cycling bipolar disorder.

Gao K, Kemp DE, Ganocy SJ, Muzina DJ, Xia G, Findling RL, Calabrese JR.

Bipolar Disord. 2008 Dec;10(8):907-15. doi: 10.1111/j.1399-5618.2008.00637.x.

PMID:
19594506

Supplemental Content

Support Center